# A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial Dysfunction

> **NCT05309135** · PHASE1 · COMPLETED · sponsor: **Aurion Biotech** · enrollment: 22 (actual)

## Conditions studied

- Corneal Edema

## Interventions

- **DRUG:** HCEC-1

## Key facts

- **NCT ID:** NCT05309135
- **Lead sponsor:** Aurion Biotech
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-24
- **Primary completion:** 2023-03-09
- **Final completion:** 2023-03-09
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2024-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05309135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05309135, "A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial Dysfunction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05309135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*